Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Budelli

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biotechnology Reports (Amsterdam, Netherlands)|February 24, 2022
Validation of an automated cell counting method for cGMP manufacturing of human induced pluripotent stem cellsPaolo Manzini, Valeria Peli, Araceli Rivera-Ordaz, et al.
Drug Design, Development and Therapy|August 29, 2015
How we make cell therapy in ItalyTiziana Montemurro, Mariele Viganò, Silvia Budelli, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 15, 2010
Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, prevents hypertensive vascular hypertrophy and fibrosisPaolo Gelosa, Gulnur Sevin, Alice Pignieri, et al.
The International Journal of Biochemistry & Cell Biology|August 15, 2013
Adipogenic potential in human mesenchymal stem cells strictly depends on adult or foetal tissue harvestEnrico Ragni, Mariele Viganò, Valentina Parazzi, et al.
Stem Cells International|September 27, 2018
Tips and Tricks for Validation of Quality Control Analytical Methods in Good Manufacturing Practice Mesenchymal Stromal Cell ProductionMariele Viganò, Silvia Budelli, Cristiana Lavazza, et al.
Journal of Cellular and Molecular Medicine|March 5, 2018
Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear PalsyAlessandra Maria Calogero, Mariele Viganò, Silvia Budelli, et al.
Cytotherapy|February 18, 2022
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studiesChiara Capelli, Simona Frigerio, Daniela Lisini, et al.
Journal of Translational Medicine|January 6, 2022
Process development and validation of expanded regulatory T cells for prospective applications: an example of manufacturing a personalized advanced therapy medicinal productCristiana Lavazza, Silvia Budelli, Elisa Montelatici, et al.
Clinical Kidney Journal|July 3, 2026
Cord blood-derived mesenchymal stromal cells in children with steroid-dependent nephrotic syndrome: a prospective phase II studyWilliam Morello, Elisa Montelatici, Cristiana Lavazza, et al.
Cells|June 26, 2024
Off-the-Shelf Cord-Blood Mesenchymal Stromal Cells: Production, Quality Control, and Clinical UseTiziana Montemurro, Cristiana Lavazza, Elisa Montelatici, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biotechnology Reports (Amsterdam, Netherlands)|February 24, 2022
Validation of an automated cell counting method for cGMP manufacturing of human induced pluripotent stem cellsPaolo Manzini, Valeria Peli, Araceli Rivera-Ordaz, et al.
Drug Design, Development and Therapy|August 29, 2015
How we make cell therapy in ItalyTiziana Montemurro, Mariele Viganò, Silvia Budelli, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 15, 2010
Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, prevents hypertensive vascular hypertrophy and fibrosisPaolo Gelosa, Gulnur Sevin, Alice Pignieri, et al.
The International Journal of Biochemistry & Cell Biology|August 15, 2013
Adipogenic potential in human mesenchymal stem cells strictly depends on adult or foetal tissue harvestEnrico Ragni, Mariele Viganò, Valentina Parazzi, et al.
Stem Cells International|September 27, 2018
Tips and Tricks for Validation of Quality Control Analytical Methods in Good Manufacturing Practice Mesenchymal Stromal Cell ProductionMariele Viganò, Silvia Budelli, Cristiana Lavazza, et al.
Journal of Cellular and Molecular Medicine|March 5, 2018
Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear PalsyAlessandra Maria Calogero, Mariele Viganò, Silvia Budelli, et al.
Cytotherapy|February 18, 2022
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studiesChiara Capelli, Simona Frigerio, Daniela Lisini, et al.
Journal of Translational Medicine|January 6, 2022
Process development and validation of expanded regulatory T cells for prospective applications: an example of manufacturing a personalized advanced therapy medicinal productCristiana Lavazza, Silvia Budelli, Elisa Montelatici, et al.
Clinical Kidney Journal|July 3, 2026
Cord blood-derived mesenchymal stromal cells in children with steroid-dependent nephrotic syndrome: a prospective phase II studyWilliam Morello, Elisa Montelatici, Cristiana Lavazza, et al.
Cells|June 26, 2024
Off-the-Shelf Cord-Blood Mesenchymal Stromal Cells: Production, Quality Control, and Clinical UseTiziana Montemurro, Cristiana Lavazza, Elisa Montelatici, et al.
Pageof 2